Altimmune, Inc. (ALT)
2.99
-0.01
(-0.33%)
USD |
NASDAQ |
Aug 04, 12:23
Altimmune Total Return Level : 11.64 for Aug. 3, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 03, 2026 | 11.64 |
| July 31, 2026 | 11.02 |
| July 30, 2026 | 11.57 |
| July 29, 2026 | 11.33 |
| July 28, 2026 | 11.60 |
| July 27, 2026 | 11.49 |
| July 24, 2026 | 10.75 |
| July 23, 2026 | 11.02 |
| July 22, 2026 | 10.91 |
| July 21, 2026 | 10.94 |
| July 20, 2026 | 10.91 |
| July 17, 2026 | 11.14 |
| July 16, 2026 | 11.06 |
| July 15, 2026 | 11.57 |
| July 14, 2026 | 11.37 |
| July 13, 2026 | 11.60 |
| July 10, 2026 | 11.84 |
| July 09, 2026 | 12.11 |
| July 08, 2026 | 12.07 |
| July 07, 2026 | 11.72 |
| July 06, 2026 | 11.95 |
| July 02, 2026 | 12.26 |
| July 01, 2026 | 12.23 |
| June 30, 2026 | 11.80 |
| June 29, 2026 | 11.41 |
| Date | Value |
|---|---|
| June 26, 2026 | 10.94 |
| June 25, 2026 | 11.14 |
| June 24, 2026 | 11.45 |
| June 23, 2026 | 11.29 |
| June 22, 2026 | 11.37 |
| June 18, 2026 | 10.48 |
| June 17, 2026 | 10.25 |
| June 16, 2026 | 10.17 |
| June 15, 2026 | 10.25 |
| June 12, 2026 | 10.13 |
| June 11, 2026 | 10.05 |
| June 10, 2026 | 10.13 |
| June 09, 2026 | 10.32 |
| June 08, 2026 | 10.60 |
| June 05, 2026 | 10.52 |
| June 04, 2026 | 11.33 |
| June 03, 2026 | 11.14 |
| June 02, 2026 | 11.26 |
| June 01, 2026 | 11.68 |
| May 29, 2026 | 11.84 |
| May 28, 2026 | 11.92 |
| May 27, 2026 | 11.57 |
| May 26, 2026 | 11.37 |
| May 22, 2026 | 11.26 |
| May 21, 2026 | 11.37 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Agenus, Inc. | 7.82 |
| Amgen, Inc. | 564.10 |
| Halozyme Therapeutics, Inc. | 82.27 |
| Protalix Biotherapeutics, Inc. | 2.32 |
| Humacyte, Inc. | 0.6893 |